Your browser doesn't support javascript.
loading
[Cancer during pregnancy: Proposal of a clinical care pathway based on a regional cohort]. / Cancer et grossesse : état des lieux en Occitanie et proposition d'un parcours de soin.
Barreau, L; Gau, S; Loussert, L; Vaysse, C; Weyl, A; Groussolles, M.
Afiliación
  • Barreau L; Maternité Paule-de-Viguier, CHU Toulouse Purpan, 330, avenue de Grande-Bretagne, TSA 70034, 31059 Toulouse cedex 9, France. Electronic address: barreau.l@chu-toulouse.fr.
  • Gau S; Institut du cancer de Montpellier Val d'Aurelle, Parc Euromédecine EU, 208, avenue des Apothicaires, 34090 Montpellier, France. Electronic address: sophie.gau@icm.unicancer.fr.
  • Loussert L; Maternité Paule-de-Viguier, CHU Toulouse Purpan, 330, avenue de Grande-Bretagne, TSA 70034, 31059 Toulouse cedex 9, France. Electronic address: loussert.l@chu-toulouse.fr.
  • Vaysse C; CHU Toulouse, Institut universitaire du cancer de Toulouse, Oncopole, 1, avenue Irène-Joliot-Curie, 31100 Toulouse, France. Electronic address: vaysse.charlotte@iuct-oncopole.fr.
  • Weyl A; CHU Toulouse, Institut universitaire du cancer de Toulouse, Oncopole, 1, avenue Irène-Joliot-Curie, 31100 Toulouse, France. Electronic address: weyl.a@chu-toulouse.fr.
  • Groussolles M; Maternité Paule-de-Viguier, CHU Toulouse Purpan, 330, avenue de Grande-Bretagne, TSA 70034, 31059 Toulouse cedex 9, France. Electronic address: m.groussolles@free.fr.
Gynecol Obstet Fertil Senol ; 50(10): 657-665, 2022 10.
Article en Fr | MEDLINE | ID: mdl-35843588
OBJECTIVES: Cancer during pregnancy affects 1 in 1000 pregnancies. This situation requires multidisciplinary team, however there is no care pathway dedicated to these patients. The main objective was to describe oncological, obstetrical, and neonatal care through a regional inventory. Our secondary objective was to define a regional "cancer and pregnancy" care pathway. MATERIAL AND METHOD: We carried out an observational, retrospective study from 2013 to 2019 including 48 women (all cancer types) from 2013 to 2019 in Occitania. Then, we defined an "optimal care pathway" and we assessed whether it was respected in the breast cancer subgroup of our cohort. RESULTS: Live births occurred in 79% of the women included. Maternal treatment was initiated during pregnancy for 67% of our population (44% chemotherapy). The most frequent pregnancy complication was preterm delivery (39%), mainly iatrogenic (86.6%). No patient in the group of breast cancer benefited from all of the ten criteria of the "optimal care pathway" that we proposed. CONCLUSIONS: A coordinated regional care pathway seems necessary to optimize communication between the healthcare providers (oncologists, gynecologists and multidisciplinary prenatal diagnosis centers, pharmacologists, pediatricians, psychologists, and general practitioners). This study identifies weaknesses in the management of women with cancer during pregnancy and suggests regional improvement opportunities.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones del Embarazo / Neoplasias de la Mama / Nacimiento Prematuro Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Female / Humans / Newborn / Pregnancy Idioma: Fr Revista: Gynecol Obstet Fertil Senol Año: 2022 Tipo del documento: Article Pais de publicación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones del Embarazo / Neoplasias de la Mama / Nacimiento Prematuro Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Female / Humans / Newborn / Pregnancy Idioma: Fr Revista: Gynecol Obstet Fertil Senol Año: 2022 Tipo del documento: Article Pais de publicación: Francia